Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Eur Acad Dermatol Venereol. 2011 Apr;25(4):383-91. doi: 10.1111/j.1468-3083.2010.03841.x. Epub 2010 Sep 14.

Psoriasis and non-alcoholic fatty liver disease.

Author information

  • 1Department of Dermatology School of Medicine, The George Washington University Medical Center, Washington, DC, USA.

Abstract

Several recent studies have found an increased prevalence of non-alcoholic fatty liver disease within psoriasis patients. The exact pathophysiological mechanisms behind these observations are unclear, but are likely related to the high prevalence of obesity and metabolic syndrome within this patient population. Chronic inflammation, mediated by either proinflammatory adipokines or skin-derived cytokines, may contribute to fatty liver disease development by increasing insulin resistance which in turn promotes hepatic lipid accumulation. These same adipokines in addition to hepatic cytokines may act on the skin to influence psoriasis disease severity.

© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

PMID:
20840346
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk